DK1251835T3 - Lukning af bakterielle spögelser - Google Patents

Lukning af bakterielle spögelser

Info

Publication number
DK1251835T3
DK1251835T3 DK01916954T DK01916954T DK1251835T3 DK 1251835 T3 DK1251835 T3 DK 1251835T3 DK 01916954 T DK01916954 T DK 01916954T DK 01916954 T DK01916954 T DK 01916954T DK 1251835 T3 DK1251835 T3 DK 1251835T3
Authority
DK
Denmark
Prior art keywords
ghosts
closed
bacterial ghosts
closure
bacterial
Prior art date
Application number
DK01916954T
Other languages
Danish (da)
English (en)
Inventor
Susanne Paukner
Werner Lubitz
Original Assignee
Lubitz Werner Prof Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lubitz Werner Prof Dr filed Critical Lubitz Werner Prof Dr
Application granted granted Critical
Publication of DK1251835T3 publication Critical patent/DK1251835T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Specific Sealing Or Ventilating Devices For Doors And Windows (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01916954T 2000-01-26 2001-01-26 Lukning af bakterielle spögelser DK1251835T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10003241A DE10003241A1 (de) 2000-01-26 2000-01-26 Verschließen von Bakterienghosts
PCT/EP2001/000864 WO2001054672A2 (fr) 2000-01-26 2001-01-26 Fermeture d'hotes bacteriens

Publications (1)

Publication Number Publication Date
DK1251835T3 true DK1251835T3 (da) 2008-12-08

Family

ID=7628743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01916954T DK1251835T3 (da) 2000-01-26 2001-01-26 Lukning af bakterielle spögelser

Country Status (12)

Country Link
US (1) US6951756B2 (fr)
EP (1) EP1251835B1 (fr)
JP (1) JP5073904B2 (fr)
AT (1) ATE404181T1 (fr)
AU (2) AU4410901A (fr)
CA (1) CA2423122C (fr)
DE (2) DE10003241A1 (fr)
DK (1) DK1251835T3 (fr)
ES (1) ES2307602T3 (fr)
NZ (1) NZ520655A (fr)
PT (1) PT1251835E (fr)
WO (1) WO2001054672A2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2450318C (fr) 2001-06-11 2011-08-02 Applied Nanosystems B.V. Methodes ameliorees pour lier des fusions d'ancrage de proteines de type acma a la paroi celluliare de micro-organismes
DE10335796A1 (de) * 2003-08-05 2005-03-03 Lubitz, Werner, Prof. Dr. Verschliessen von Bakterienghosts durch bioaffine Wechselwirkungen
EP1654364A4 (fr) * 2003-08-13 2008-02-13 Novartis Vaccines & Diagnostic Liberation de cellule hote inactivee comprenant des polynucleotides codant pour des immunogenes
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
EP1687017B1 (fr) 2003-10-24 2013-03-06 Gencia Corporation Procédés et compositions permettant de distribuer des polynucleotides
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US8029777B2 (en) * 2004-08-13 2011-10-04 Marshall Barry J Helicobacter system and uses thereof
EP1789094B1 (fr) * 2004-08-13 2014-12-10 MARSHALL, Barry J. Vecteur d'administration bactérien
GB2424408A (en) * 2005-03-24 2006-09-27 Micap Plc Encapsulation using microbial cells
PT2240570E (pt) 2008-01-18 2014-02-17 Werner Lubitz Processo de produção de fantasmas bacterianos (bg) utilizando betapropiolactona (blp) para inactivação final
CN101658668B (zh) * 2009-07-15 2012-01-25 吉林大学 利用抗菌肽制备细菌菌影的方法及应用
EP2485764A4 (fr) * 2009-10-09 2014-01-29 Childrens Medical Center Vaccin à cellules entières à dissociation sélective
WO2012002760A2 (fr) 2010-07-01 2012-01-05 포항공과대학교 산학협력단 Méthode de diagnostic et de traitement du cancer par des microvésicules cellulaires
WO2013034687A1 (fr) 2011-09-09 2013-03-14 Universität Bern Verwaltungsdirektion Toxine rtx d'avibacterium paragallinarum
PL2591798T3 (pl) * 2011-11-09 2015-04-30 Werner Lubitz Szczepionka do zastosowania w immunoterapii nowotworów
EP3195878A1 (fr) 2016-01-22 2017-07-26 Werner Lubitz Hôtes bactériens pour le traitement du cancer
EP3658125A4 (fr) * 2017-07-28 2021-04-28 National University of Singapore Composites biomoléculaires comprenant des fantômes cellulaires modifiés
CN111491655A (zh) 2017-08-07 2020-08-04 加利福尼亚大学董事会 用于生成安全细胞治疗剂的平台
US10960071B2 (en) * 2017-08-07 2021-03-30 The Regents Of The University Of California Platform for generating safe cell therapeutics
EP3700552A1 (fr) 2017-10-25 2020-09-02 Allero Therapeutics BV Traitement de maladies immunitaires par l'administration de formulations spécifiques à des antigènes
CN108324956A (zh) * 2018-03-06 2018-07-27 东北农业大学 一种以大肠杆菌菌影为载体装载紫杉醇药物的制备方法
CN108587961A (zh) * 2018-04-28 2018-09-28 南华大学 一种制备大肠埃希菌菌影并装载dna质粒的方法
EP4013392A4 (fr) * 2019-09-13 2023-07-19 Exocure Biosciences, Inc. Utilisation de nanovésicules fantômes en tant qu'agents thérapeutiques
WO2023019389A1 (fr) * 2021-08-16 2023-02-23 Xianzhong Yu Fantômes bactériens fermés, et compositions, procédés et utilisations de ceux-ci

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3269886D1 (en) * 1981-11-21 1986-04-17 Dunlop Ltd Process for encapsulating substances by means of microorganisms, and the encapsulated products obtained thereby
JPS6188871A (ja) * 1984-10-04 1986-05-07 Mitsubishi Paper Mills Ltd 感圧性バイオカプセル
JPS62186937A (ja) * 1986-02-10 1987-08-15 Mitsubishi Paper Mills Ltd マイクロカプセルの製造方法
DD246476A1 (de) * 1986-03-12 1987-06-10 Karl Marx Stadt Tech Hochschul Einteilige zementfrei verankerbare biokompatible hueftgelenkpfanne
JPH0732870B2 (ja) * 1990-04-20 1995-04-12 三菱製紙株式会社 マイクロカプセルの製造方法
GB9509937D0 (en) * 1995-05-17 1995-07-12 Cpc International Inc Encapsulated product
JPH10102288A (ja) * 1996-09-24 1998-04-21 Queen Mary & Westfield College リン酸カルシウム化合物のコーティング方法
US6013591A (en) * 1997-01-16 2000-01-11 Massachusetts Institute Of Technology Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production
US6129928A (en) * 1997-09-05 2000-10-10 Icet, Inc. Biomimetic calcium phosphate implant coatings and methods for making the same

Also Published As

Publication number Publication date
EP1251835A2 (fr) 2002-10-30
NZ520655A (en) 2004-09-24
PT1251835E (pt) 2008-11-25
US20030003511A1 (en) 2003-01-02
JP5073904B2 (ja) 2012-11-14
WO2001054672A3 (fr) 2002-01-17
ATE404181T1 (de) 2008-08-15
EP1251835B1 (fr) 2008-08-13
ES2307602T3 (es) 2008-12-01
AU2001244109B2 (en) 2004-12-02
CA2423122A1 (fr) 2003-03-19
WO2001054672A2 (fr) 2001-08-02
AU2001244109B9 (en) 2005-05-26
AU4410901A (en) 2001-08-07
DE10003241A1 (de) 2001-08-02
CA2423122C (fr) 2014-04-01
DE50114213D1 (de) 2008-09-25
JP2003521494A (ja) 2003-07-15
US6951756B2 (en) 2005-10-04

Similar Documents

Publication Publication Date Title
DK1251835T3 (da) Lukning af bakterielle spögelser
GEP20094620B (en) Irinotecan preparation
WO2007077217A3 (fr) Milieux de culture cellulaire dépourvus d'oligopeptides
WO2009091912A3 (fr) Vecteurs d'expression de mammifère améliorés et leurs utilisations
WO2007044418A3 (fr) Milieux de culture cellulaire, kits et procédés d’utilisation
DK1196196T3 (da) Konjugat til formidling af en celle-, compartment- eller membranspecifik transport af aktivstoffer
WO2003021265A8 (fr) Systeme de controle intracellulaire d'un produit de recombinaison genetique
Utsugi et al. Strategies for post-translational control of protein expression and their applications
DE60107718T8 (de) Konservierung von zellen
EE05691B1 (et) Ekspressioonivektorid ja nende rakendused
WO2005123903A3 (fr) Auxiliaire de culture pour cellules et tissus
WO2011104612A3 (fr) Dispositif pour la culture et l'analyse cellulaires
Köhler Cellular Microbiology, Pascale Cossart, Patrice Bouquet, Staffan Normark, Rino Rappuoli (Eds.), ASM Press, Washington, DC (2004),(593pp., 124 figures, 12 color plates, 39 tables, price US $119.95 hardcover), ISBN: 1-55581-302-X
CA2666415A1 (fr) Reactif contenant une proteine fusionnee de rankl soluble avec un marqueur d'epitope
CA2534612A1 (fr) Scellement d'hotes bacteriens par des interactions a affinite biologique
Malda et al. Does scaffold architecture influence oxygen gradients in cartilaginous tissue engineered constructs?
WO2002047479A3 (fr) Clonage de bovins par transplantation nucleaire
Phalen Analysis of the Semliki Forest virus requirement for cholesterol during membrane fusion and infection
WO2000075291A3 (fr) Expression forcee de bcl-xl
Tollefson Garden Planting Welcomes Summer to Campus
IL154690A0 (en) Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures
CN108966941A (zh) 一种组合塑料膜
Mengistu et al. Physical Properties of the Transcytosis Machinery in Endothelial Cells
UA58783U (ru) Способ культивирования личинок стронгилят при желудочно-кишечных стронгилятозах крупного рогатого скота
Kawano et al. Development of a scaffold composed of a hydrogel particle monolayer for tissue regeneration